ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,463,288 | +15.6% | 473,556 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $1,266,305 | +101611.2% | 469,002 | +11.9% | 0.00% | 0.0% |
| Q1 2023 | $1,245 | +183.0% | 419,067 | +140.2% | 0.00% | – |
| Q4 2022 | $440 | -99.9% | 174,475 | -57.1% | 0.00% | – |
| Q3 2022 | $740,000 | -28.1% | 406,761 | +24.5% | 0.00% | -100.0% |
| Q2 2022 | $1,029,000 | -17.6% | 326,730 | +61.7% | 0.00% | 0.0% |
| Q1 2022 | $1,249,000 | -35.1% | 202,047 | +49.1% | 0.00% | 0.0% |
| Q4 2021 | $1,925,000 | -3.2% | 135,550 | -45.5% | 0.00% | 0.0% |
| Q3 2021 | $1,989,000 | +211.8% | 248,687 | +1014.3% | 0.00% | – |
| Q2 2021 | $638,000 | -45.0% | 22,318 | -44.2% | 0.00% | -100.0% |
| Q1 2021 | $1,161,000 | +138.9% | 39,969 | -2.0% | 0.00% | – |
| Q4 2020 | $486,000 | +11.7% | 40,769 | -35.3% | 0.00% | -100.0% |
| Q3 2020 | $435,000 | – | 62,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |